103 related articles for article (PubMed ID: 10961691)
81. Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5 '-triphosphate (ribavirin-TP).
Borowski P; Lang M; Niebuhr A; Haag A; Schmitz H; Schulze zur Wiesch J; Choe J; Siwecka MA; Kulikowski T
Acta Biochim Pol; 2001; 48(3):739-44. PubMed ID: 11833782
[TBL] [Abstract][Full Text] [Related]
82. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
Locatelli GA; Gosselin G; Spadari S; Maga G
J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
[TBL] [Abstract][Full Text] [Related]
83. Inhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses.
Bretner M; Najda A; Podwińska R; Baier A; Paruch K; Lipniacki A; Piasek A; Borowski P; Kulikowski T
Acta Pol Pharm; 2004 Dec; 61 Suppl():26-8. PubMed ID: 15909930
[TBL] [Abstract][Full Text] [Related]
84. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses.
Borowski P; Deinert J; Schalinski S; Bretner M; Ginalski K; Kulikowski T; Shugar D
Eur J Biochem; 2003 Apr; 270(8):1645-53. PubMed ID: 12694177
[TBL] [Abstract][Full Text] [Related]
85. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.
Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P
J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067
[TBL] [Abstract][Full Text] [Related]
86. NTPase/helicase of Flaviviridae: inhibitors and inhibition of the enzyme.
Borowski P; Niebuhr A; Schmitz H; Hosmane RS; Bretner M; Siwecka MA; Kulikowski T
Acta Biochim Pol; 2002; 49(3):597-614. PubMed ID: 12422230
[TBL] [Abstract][Full Text] [Related]
87. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
88. Recent advances in the discovery of small molecule therapies for HCV.
Myles DC
Curr Opin Drug Discov Devel; 2001 Jul; 4(4):411-6. PubMed ID: 11727306
[TBL] [Abstract][Full Text] [Related]
89. The role of nucleoside triphosphate hydrolase metallochaperones in making metalloenzymes.
Vaccaro FA; Drennan CL
Metallomics; 2022 Jun; 14(6):. PubMed ID: 35485745
[TBL] [Abstract][Full Text] [Related]
90. [Use of ribavirin in viruses other than hepatitis C. A review of the evidence].
Ramírez-Olivencia G; Estébanez M; Membrillo FJ; Ybarra MDC
Enferm Infecc Microbiol Clin; 2019 Nov; 37(9):602-608. PubMed ID: 38620198
[TBL] [Abstract][Full Text] [Related]
91. ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy.
Borowski P; Mueller O; Niebuhr A; Kalitzky M; Hwang LH; Schmitz H; Siwecka MA; Kulikowsk T
Acta Biochim Pol; 2000; 47(1):173-80. PubMed ID: 10961691
[TBL] [Abstract][Full Text] [Related]
92. Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy.
Borowski P; Schalinski S; Schmitz H
Antiviral Res; 2002 Sep; 55(3):397-412. PubMed ID: 12206878
[TBL] [Abstract][Full Text] [Related]
93.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
94.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
95.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
